Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 03 Mar 2023
FGF21 Inflammation associated with indicators of nutritional status in patients with IBD
Read Full NewsIn patients with newly diagnosed fibromyalgia who have prominent symptoms of anxiety and depression, remission of depression — not pain reduction alone — determines clinical improvement.
Most ADHD coaches do not have behavioral health training, a study finds, but experts say peer support can help people navigate living with the condition.
In the long term, stereotactic body radiotherapy carries a lower risk for biochemical failure vs high-dose rate brachytherapy for men with intermediate-risk prostate cancer.
1.
Cancer and HIV Vaccines Enter the Therapeutic Era
2.
Genetics and Genetic Testing to Inform Myelofibrosis Clinical Management.
3.
'Personalized' Approach to RT for Bladder Cancer Promising but Challenging
4.
Study finds 10% of pediatric blood cancers may stem from medical imaging radiation
5.
According to JAMA, even four minutes a day of exercise can lower the risk of cancer.
1.
Mastering Breast Cancer Care in 2025: Diagnosis, Treatment, Education, and Innovation
2.
Mastering Surgical Oncology: Education, Certification, Trials, and Therapy Insights
3.
Immuno-Oncology in Daily Practice: Transforming Cancer Care One Patient at a Time
4.
Cerebrospinal Fluid Metabolite Biomarkers in Central Nervous System Tumor Monitoring: A New Frontier
5.
Ultimate Guide to Oncology Services in the USA
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
A New Era in Managing Cancer-Associated Thrombosis
2.
Preventing Blood Clots: The Importance of Venous Thromboembolism Management
3.
Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer
4.
Efficient Management of First line ALK-rearranged NSCLC - Part V
5.
The Evolving Landscape of First-Line Treatment for Urothelial Carcinoma
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge